Havn Life Sciences announces increase in Bought Deal Financing to $10 Million

VANCOUVER, British Columbia, Dec. 15, 2020 (GLOBE NEWSWIRE) — Havn Life Sciences…

Havn Life Sciences Undertakes One of the First Preclinical Studies on Psilocybin and the Immune System

This is one of the first studies to examine how psilocybin affects…

Havn Life Sciences to Supply Psychedelic Compounds to Clinical Studies Focused on Veterans and PTSD

Havn Life will collaborate on future clinical studies with Heroic Hearts Project…

Havn Life Sciences Partners With Veterans Mental Health Non-Profit, Westwood Institute

Westwood Institute Founder, Dr. Marvin Westwood Will Work With Havn Life’s Research…

Havn Life Attracts International Drug Science and Policy Expert, Joins UK Policy Reform Group

Havn Life Has Joined the UK-Based Conservative Drug Policy Reform Group (CDPRG),…

GT Biopharma Announces Dr. Greg Berk, M.D. Joins Board of Directors

BEVERLY HILLS, CA / ACCESSWIRE / November 19, 2020 / GT Biopharma,…

Havn Life announces Voluntary Escrow of 6,300,000 Shares

The Voluntary Escrow serves further validates investors belief and support of Havn…

GT Biopharma Appoints Michael Handelman, CPA as Chief Financial Officer

BEVERLY HILLS, CA / ACCESSWIRE / November 18, 2020 / GT Biopharma,…

GT Biopharma Announces Former Abraxis CEO, Bruce J. Wendel as Vice Chairman of GTBP Board of Directors

BEVERLY HILLS, CA / ACCESSWIRE / November 17, 2020 / PGT Biopharma,…

GT Biopharma Announces Publication of GTB-3550 TriKE Interim Results at the Prestigious 62nd American Society of Hematology (ASH) Annual Meeting

TAMPA, FL / ACCESSWIRE / November 12, 2020 / GT Biopharma, Inc. (OTCQB:GTBP)…